Norbert Gleicher

This inventor holds 15 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: American Infertility of New York, The Center for Human Reproduction (Chr), University of Rochester. Active years: 2009-2021.

USPTO Granted Patents = 15 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 20(Granted Patents)

Location History:

Chicago, IL (US) (2009 - 2014)
New York City, NY (US) (2015)
New York, NY (US) (2015 - 2021)

Company Filing History:

7 out of 7

American Infertility of New York

patents

1 out of 1

The Center for Human Reproduction (Chr)

patent

1 out of 994

University of Rochester

patents

4. 1 out of 1

Women's Lab Company, LLC

patent

5. 7 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10884003 - Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models (2021-01-05),

2. 10478473 - Compositions and methods of using anti-mullerian hormone for treatment of infertility (2019-11-19),

3. 10175252 - Diagnosis, and anti-mullerian hormone (AMH) administration for treatment, of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models (2019-01-08),

4. 9974834 - Administration to improve oocyte retrieval probabilities (2018-05-22),

5. 9375436 - Androgen treatment in females (2016-06-28),

6. 9205092 - Androgen treatment in females (2015-12-08),

7. 9157117 - Screening of oocyte donor candidates based on the FMR1 gene (2015-10-13),

8. 9114153 - Methods of treatment relating to the FMR1 gene (2015-08-25),

9. 9056115 - Androgen treatment in females (2015-06-16),

10. 8951724 - Detection of infertility risk and premature ovarian aging (2015-02-10),

11. 8629120 - [object Object] (2014-01-14),

12. 8501719 - Androgen treatment in females (2013-08-06),

13. 8501718 - Androgen treatment in females (2013-08-06),

14. 8067400 - Androgen treatment in females (2011-11-29),

15. 7615544 - Method of improving cumulative embryo score and quantity of fertilized oocytes, increasing euploidy rate and of normalizing ovarian function using an androgen such as dehydroepiandrosterone (2009-11-10),

Title: Norbert Gleicher: Innovator in Infertility Treatment

Introduction

Norbert Gleicher is a prominent inventor based in New York, NY, known for his significant contributions to the field of infertility treatment. With a total of 15 patents to his name, he has made remarkable advancements that have the potential to change the lives of many individuals facing fertility challenges.

Latest Patents

Gleicher's latest patents include innovative methods for diagnosing and administering anti-Mullerian hormone (AMH) for the treatment of infertility. One notable patent focuses on the diagnosis of in vitro fertilization (IVF) viability through logistic regression models. This method involves determining a subject's AMH level and categorizing their pregnancy or live birth prognosis based on established AMH ranges. The prognosis categories include good, intermediate, or poor, which guide the administration of AMH to enhance the chances of pregnancy or live birth. Additionally, his work encompasses compositions and methods for treating subjects with impaired fertility by increasing the level or activity of AMH.

Career Highlights

Throughout his career, Gleicher has worked with various organizations, including American Infertility of New York. His expertise in the field has led to numerous breakthroughs that have been instrumental in advancing infertility treatments.

Collaborations

Gleicher has collaborated with notable professionals in the field, including David H. Barad and Dwyn V. Harben. These partnerships have contributed to the development of innovative solutions for infertility.

Conclusion

Norbert Gleicher's work in the field of infertility treatment exemplifies the impact of innovation on healthcare. His patents and collaborations continue to pave the way for improved fertility solutions, making a significant difference in the lives of many.